Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

Vascular Damage in Children With Chronic Kidney Disease

The Fog Is Dispersing

Luminita Voroneanu, Adrian Covic
Download PDF
https://doi.org/10.1161/HYPERTENSIONAHA.117.08770
Hypertension. 2017;69:791-794
Originally published April 3, 2017
Luminita Voroneanu
From the Nephrology Department, Dialysis and Renal Transplant Center, “Dr C.I. Parhon” University Hospital, Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Covic
From the Nephrology Department, Dialysis and Renal Transplant Center, “Dr C.I. Parhon” University Hospital, Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

See related article, pp 863–869

Children with chronic kidney disease (CKD) have an increased mortality risk during childhood and as a young adult. Precisely, the lifespan of a pediatric patient on dialysis is shortened by 50 years compared with that of control individuals, matched for age and ethnicity.1 Children with end-stage renal disease have a 10-year survival rate of ≈80% and an age-specific mortality rate of ≈30× that seen in children without end-stage renal disease.2 In spite of a lower exposure to classical risk factors (diabetes mellitus, smoking, and hyperlipidemia), the most common cause of death in these children is cardiovascular disease. Hypertension, alterations in mineral metabolism, anemia, or chronic inflammation may explain part of this increased cardiovascular risk. In adults with CKD, increased aortic stiffness may lead to left ventricular hypertrophy and left ventricular dysfunction and is an important independent predictor of future cardiovascular events and mortality.

In children with moderate to severe CKD, there are fewer reports showing that arterial stiffness may contribute to cardiovascular morbidity or mortality. In addition, carotid-femoral pulse wave velocity (cfPWV) assessed by applanation tonometry—the most commonly used measure of arterial stiffness—may be challenging to measure, especially in younger children, because it is time-consuming and require patient collaboration.3 Finally, even if the patient is cooperative, it can be more difficult to maintain a sufficiently strong signal from the smaller arteries of younger children. It also requires a trained operator and access to the femoral artery in the inguinal area—a potentially disturbing maneuver, particularly in adolescents. Oscillometric assessment of pulse wave velocity (PWV) using a pressure cuff has the advantages of being quick, convenient, and operator independent.3

In the last 10 years, several important papers describing arterial stiffness in pediatric population with CKD have been published; importantly, these studies were mostly focused on end-stage renal disease (see Table). In children with end-stage renal disease, on dialysis, cfPWV and augmentation index are increased compared with those in healthy subjects.4,7 A direct correlation between the time spent on dialysis and deterioration of vascular function was described; this decline was also associated with abnormal levels of calcium, phosphorus, and parathyroid hormone, as well as with dyslipidemia and increased blood pressure (BP).4,10 There are some reports suggesting improvements in arterial abnormalities post-transplant. However, subclinical arteriopathy is still present in young transplant recipients. Transplanted patients have a significantly higher PWV compared with controls; PWV is correlated with systolic BP and age.6,10

View this table:
  • View inline
  • View popup
Table.

Arterial Stiffness in CKD, Dialysis, and Renal Transplantation

In children with predialysis CKD, available data are scarce. In the last year, 2 important papers were published, the last one in this issue of Hypertension.12 In the first one, Sinha et al11 measured common carotid artery mechanical properties, cfPWV, carotid, and peripheral BP in children with CKD from the Evelina London Children’s Hospital (n=188; 11.9±3.7 years; 26%, 25%, 30%, 16%, and 3% in CKD stages 1, 2, 3, 4 and 5, respectively) and in healthy controls (n=38; 11.5±3.3 years).11 The authors found that (1) cfPWV values did not differ between children with CKD and healthy controls (5.3±0.9 versus 5.3±0.8 m/s, respectively) and were not significantly related to glomerular filtration rate (GFR); (2) when children with CKD and suboptimal BP control (values ≥75th percentile) are compared with normotensive controls, there are significant differences in functional elastic properties of the carotid artery (distensibility: 92±31 versus 114±33 kPa−1 ×10−3, P=0.03; compliance: 2.1±0.7 versus 2.6±0.7 m2 kPa−1 ×10−6, P=0.02; Young elastic modulus: 0.151±0.068 versus 0.109±0.049 kPa ×103, P=0.02; and wall stress: 83.6±23.5 versus 68.7±14.9 kPa, P=0.02); but not in cfPWV.

Savant et al,12 in this issue of Hypertension, compared cfPWV, assessed via applanation tonometry in children enrolled in the CKiD (Chronic Kidney Disease in Children) cohort to normative data from healthy children and examined risk factors associated with elevated cfPWV.11 Of the 95 participants with measured cfPWV, 60% were male, 19% were black, mean age was 15.1 years, average mean arterial pressure was 80 mm Hg, and median GFR was 63 mL/min per 1.73 m2; 91 participants had an iohexol-measured GFR, and for the remaining 4 participants, the authors used an estimated GFR. The main findings are as follows: (1) cfPWV increased significantly with age and mean arterial pressure, but not with GFR; (2) arterial stiffness was comparable to that of normal children. Importantly, the normative cfPWV data in healthy children was assessed using the PulsePen device, while cfPWV in CKD children was measured using the SphygmoCor device; a previous paper showed that data obtained by the 2 devices are in accordance with each other, the mean difference between cfPWV measured by SphygmoCor and PulsePen being 0.12 ±0.77 m/s.13 However, the limits of agreement between SphygmoCor and PulsePen cfPWV were −1.5 to 1.5 m/s. As the current mean cfPWV was 5.0 m/s in the CKiD study cohort, it is important to note that a limit of agreement of 3 m/s represents an error of 60%.

The authors also found that black race, which was significantly associated with elevated cfPWV in univariable analysis, retained significance after controlling for other factors in the multivariable analysis. The increased arterial stiffness for the black race compared with whites was also described in other cohort (adolescents and young adults with type 2 diabetes mellitus and also in adults with CKD). The number of black patients included in this study was small; thus, the interaction between race and the progression of arterial stiffness and cardiovascular damage in CKD will be interesting to follow in future research.

Although important, this study has several important limitations: (1) this is only a cross-sectional analysis; the prospective design of the CKiD study will allow longitudinal assessments of cfPWV, which could help reveal cfPWV changes as kidney function declines; (2) the presence of multiple operators at different clinical sites could have biased the results; (3) participants enrolled in the CKiD study–North American multicenter pediatric cohort may differ from the general population of children with CKD; (4) the relatively preserved kidney function, supported by a median GFR of 63 mL/min per 1.73 m2. In addition, this cohort had a relatively large proportion of children with shorter disease duration and, hence, less exposure to reduced GFR, elevated BP, and other factors that may contribute to increase PWV.

These 2 trials are important contributions toward defining knowledge: in both, the authors found that arterial stiffness did not differ between CKD and healthy controls and were not significantly related to eGFR. In contrast, structural and functional alterations, including increased arterial wall thickness and stiffness in children on dialysis compared with healthy controls, have been described. The relatively preserved kidney function (median GFR of 54 mL/min, respectively, 63 mL/min per 1.73 m2) could be a possible explanation for such contradictory findings.

A comparable value of cfPWV in children with or without CKD does not exclude the existence of early significant subclinical vascular damage. Epidemiological and clinical studies have provided ample evidence that functional and structural damage begins early in the course of renal failure and progress markedly after dialysis start.

The best evidence supporting this disconnection between available measures of vascular functional damage and molecular significant abnormalities was provided by Shroff et al5 in an elegant study combining ex vivo vessels investigations with artery intima–media thickness and cfPWV in the same subjects. The authors found that all predialysis and 25% of dialysis vessels have normal carotid artery intima–media thickness, despite significant calcium accumulation in the vessel wall. Moreover, vessel stiffness, as measured by PWV, and coronary calcification on a computed tomography scan were seen in only 2 children with the highest vessel calcium loads.

In this context, current data suggests that our clinical investigation tools are not sensitive enough to detect early stages of calcification and arteriosclerosis in children with CKD and underlying vessel damage. We still consider that in children with CKD, we should include the assessment of vascular function (arterial stiffness, intima–media thickness) in the initial evaluation of these patients. Based on recent data, more attention should be given to patients with suboptimal BP control or from black descent.

Disclosures

Adrian Covic has received consultancy fees Fresenius Medical Care and Astellas. The other author reports no conflicts.

Footnotes

  • The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.

  • © 2017 American Heart Association, Inc.

References

  1. 1.↵
    1. Mak RH
    . Chronic kidney disease in children: state of the art. Pediatr Nephrol. 2007;22:1687–1688. doi: 10.1007/s00467-006-0360-7.
    OpenUrlPubMed
  2. 2.↵
    1. Becherucci F,
    2. Roperto RM,
    3. Materassi M,
    4. Romagnani P
    . Chronic kidney disease in children. Clin Kidney J. 2016;9:583–591. doi: 10.1093/ckj/sfw047.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Savant JD,
    2. Furth SL,
    3. Meyers KE
    . Arterial stiffness in children: pediatric measurement and considerations. Pulse (Basel). 2014;2:69–80. doi: 10.1159/000374095.
    OpenUrl
  4. 4.↵
    1. Covic A,
    2. Mardare N,
    3. Gusbeth-Tatomir P,
    4. Brumaru O,
    5. Gavrilovici C,
    6. Munteanu M,
    7. Prisada O,
    8. Goldsmith DJ
    . Increased arterial stiffness in children on haemodialysis. Nephrol Dial Transplant. 2006;21:729–735. doi: 10.1093/ndt/gfi196.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Shroff RC,
    2. McNair R,
    3. Figg N,
    4. Skepper JN,
    5. Schurgers L,
    6. Gupta A,
    7. Hiorns M,
    8. Donald AE,
    9. Deanfield J,
    10. Rees L,
    11. Shanahan CM
    . Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008;118:1748–1757. doi: 10.1161/CIRCULATIONAHA.108.783738.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Briese S,
    2. Claus M,
    3. Querfeld U
    . Arterial stiffness in children after renal transplantation. Pediatr Nephrol. 2008;23:2241–2245. doi: 10.1007/s00467-008-0894-y.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Kis E,
    2. Cseprekál O,
    3. Horváth Z,
    4. Katona G,
    5. Fekete BC,
    6. Hrapka E,
    7. Szabó A,
    8. Szabó AJ,
    9. Fekete A,
    10. Reusz GS
    . Pulse wave velocity in end-stage renal disease: influence of age and body dimensions. Pediatr Res. 2008;63:95–98. doi: 10.1203/PDR.0b013e31815b47ff.
    OpenUrlCrossRefPubMed
  8. 8.
    1. Cseprekál O,
    2. Kis E,
    3. Schäffer P,
    4. Othmane Tel H,
    5. Fekete BC,
    6. Vannay A,
    7. Szabó AJ,
    8. Remport A,
    9. Szabó A,
    10. Tulassay T,
    11. Reusz GS
    . Pulse wave velocity in children following renal transplantation. Nephrol Dial Transplant. 2009;24:309–315. doi: 10.1093/ndt/gfn494.
    OpenUrlAbstract/FREE Full Text
  9. 9.
    1. Aoun B,
    2. Lorton F,
    3. Wannous H,
    4. Lévy B,
    5. Ulinski T
    . Aortic stiffness in ESRD children before and after renal transplantation. Pediatr Nephrol. 2010;25:1331–1336. doi: 10.1007/s00467-010-1509-y.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Tawadrous H,
    2. Kamran H,
    3. Salciccioli L,
    4. Schoeneman MJ,
    5. Lazar J
    . Evaluation of arterial structure and function in pediatric patients with end-stage renal disease on dialysis and after renal transplantation. Pediatr Transplant. 2012;16:480–485. doi: 10.1111/j.1399-3046.2012.01721.x.
    OpenUrlPubMed
  11. 11.↵
    1. Sinha MD,
    2. Keehn L,
    3. Milne L,
    4. Sofocleous P,
    5. Chowienczyk PJ
    . Decreased arterial elasticity in children with nondialysis chronic kidney disease is related to blood pressure and not to glomerular filtration rate. Hypertension. 2015;66:809–815. doi: 10.1161/HYPERTENSIONAHA.115.05516.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Savant JD,
    2. Betoko A,
    3. Meyers KEC,
    4. Mitsnefes M,
    5. Flynn JT,
    6. Townsend RR,
    7. Greenbaum LA,
    8. Dart A,
    9. Warady B,
    10. Furth SL
    . Vascular stiffness in children with chronic kidney disease. Hypertension. 2017;69:863–869. doi: 10.1161/HYPERTENSIONAHA.116.07653.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Kis E,
    2. Cseprekál O,
    3. Kerti A,
    4. Salvi P,
    5. Benetos A,
    6. Tisler A,
    7. Szabó A,
    8. Tulassay T,
    9. Reusz GS
    . Measurement of pulse wave velocity in children and young adults: a comparative study using three different devices. Hypertens Res. 2011;34:1197–1202. doi: 10.1038/hr.2011.103.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
May 2017, Volume 69, Issue 5
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Vascular Damage in Children With Chronic Kidney Disease
    Luminita Voroneanu and Adrian Covic
    Hypertension. 2017;69:791-794, originally published April 3, 2017
    https://doi.org/10.1161/HYPERTENSIONAHA.117.08770

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Vascular Damage in Children With Chronic Kidney Disease
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Vascular Damage in Children With Chronic Kidney Disease
    Luminita Voroneanu and Adrian Covic
    Hypertension. 2017;69:791-794, originally published April 3, 2017
    https://doi.org/10.1161/HYPERTENSIONAHA.117.08770
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Cardiology
    • Etiology
      • Hypertension
        • Hypertension

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured